Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: A cohort study

Breast Cancer Research and Treatment

Volumn 114, Issue 1, 2009, Pages 113-120

  Cui, Yan ^a   Page, David L ^b   Lane, Dorothy S ^c   Rohan, Thomas E ^d  

^a Office of Health Assessment and Epidemiology   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Benign proliferative epithelial disorders of the breast; Menstrual history; Postmenopausal hormone use; Reproductive history

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST HYPERPLASIA; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REPRODUCTION; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOPSY; BREAST DISEASES; CHILD; ESTROGEN REPLACEMENT THERAPY; FEMALE; HORMONES; HUMANS; HYPERPLASIA; MENSTRUATION; MIDDLE AGED; POSTMENOPAUSE; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCTION; RISK FACTORS; TIME FACTORS;

EID: 58849143074     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9973-9     Document Type: Article

References (34)

1. Rohan TE, Kandel RA (2002) Breast. In: Franco EL, Rohan TE (eds) Cancer precursors: epidemiology, detection, and prevention. Springer-Verlag, New York
2. PL Fitzgibbons DE Henson RV Hutter 1998 Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists Arch Pathol Lab Med 122 1053 1055
3. SR Lakhani 1999 The transition from hyperplasia to invasive carcinoma of the breast J Pathol 187 272 278
4. BE Henderson HS Feigelson 2000 Hormonal carcinogenesis Carcinogenesis 21 427 433
5. GS Berkowitz JL Kelsey VA LiVolsi 1984 Exogenous hormone use and fibrocystic breast disease by histopathologic component Int J Cancer 34 443 449
6. GS Berkowitz JL Kelsey VA LiVolsi 1985 Risk factors for fibrocystic breast disease and its histopathologic components J Natl Cancer Inst 75 43 50
7. RA Bright AS Morrison J Brisson 1989 Histologic and mammographic specificity of risk factors for benign breast disease Cancer 64 653 657
8. C Friedenreich H Bryant F Alexander 2000 Risk factors for benign proliferative breast disease Int J Epidemiol 29 637 644
9. CC Hsieh AM Walker EJ Trapido 1984 Age at first birth and breast atypia Int J Cancer 33 309 312
10. VA LiVolsi BV Stadel JL Kelsey 1978 Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia N Engl J Med 299 381 385
11. Y Minami N Ohuchi Y Taeda 1998 Risk factors for benign breast disease according to histopathological type: comparisons with risk factors for breast cancer Jpn J Cancer Res 89 116 123
12. H Pastides JL Kelsey VA LiVolsi 1983 Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology J Natl Cancer Inst 71 5 9
13. TE Rohan KA L'Abbe MG Cook 1992 Oral contraceptives and risk of benign proliferative epithelial disorders of the breast Int J Cancer 50 891 894
14. TE Rohan AB Miller 1999 A cohort study of oral contraceptive use and risk of benign breast disease Int J Cancer 82 191 196
15. TE Rohan AB Miller 1999 Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast Eur J Cancer Prev 8 123 130
16. I Soini R Aine K Lauslahti 1981 Independent risk factors of benign and malignant breast lesions Am J Epidemiol 114 507 514
17. The Women's Health Initiative Study Group 1998 Design of the Women's Health Initiative clinical trial and observational study Control Clin Trials 19 61 109
18. RD Jackson AZ LaCroix JA Cauley 2003 The women's health initiative calcium-vitamin D trial: overview and baseline characteristics of participants Ann Epidemiol 13 S98 S106
19. C Ritenbaugh RE Patterson RT Chlebowski 2003 The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants Ann Epidemiol 13 S87 S97
20. ML Stefanick BB Cochrane J Hsia 2003 The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants Ann Epidemiol 13 S78 S86
21. LC Hartmann TA Sellers MH Frost 2005 Benign breast disease and the risk of breast cancer N Engl J Med 353 229 237
22. Y Cui DL Page RT Chlebowski 2007 Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative Cancer Causes Control 18 431 438
23. Y Cui DL Page RT Chlebowski 2007 Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast Int J Cancer 121 1346 1351
24. Rothman JK, Greenland S (eds) (1998) Modern epidemiology. Lippincott-Raven, Philadelphia (PA)
25. T Key P Appleby I Barnes 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 606 616
26. Collaborative Group on Hormonal Factors in Breast Cancer 1997 Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 1047 1059
27. JE Rossouw GL Anderson RL Prentice 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 321 333
28. C Schairer D Hill SR Sturgeon 2005 Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women Cancer Epidemiol Biomarkers Prev 14 1660 1665
29. JD Jacquemier PH Rolland D Vague 1982 Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast Cancer 49 2534 2536
30. C Giani E D'Amore JC Delarue 1986 Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features Int J Cancer 37 7 10
31. E Tan-Chiu J Wang JP Costantino 2003 Effects of tamoxifen on benign breast disease in women at high risk for breast cancer J Natl Cancer Inst 95 302 307
32. GL Anderson M Limacher AR Assaf 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 1701 1712
33. JM Cline G Soderqvist E von Schoultz 1996 Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques Am J Obstet Gynecol 174 93 100
34. MG Cook TE Rohan 1985 The patho-epidemiology of benign proliferative epithelial disorders of the female breast J Pathol 146 1 15